Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

Barbara De Moerloose,1 Stefan Suciu,2 Yves Bertrand,3 Françoise Mazingue,4 Alain Robert,5 Anne Uyttebroeck,6 Karima Yakouben,7 Alice Ferster,8 Geneviève Margueritte,9 Patrick Lutz,10 Martine Munzer,11 Nicolas Sirvent,12 Lucilia Norton,13 Patrick Boutard,14 Dominique Plantaz,15 Frederic Millot,16 Pierre Philippet,17 Liliana Baila,2 Yves Benoit,1 and Jacques Otten,18 for the Children’s Leukemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC)

[1]  C. Pui,et al.  Current management and challenges of malignant disease in the CNS in paediatric leukaemia. , 2008, The Lancet. Oncology.

[2]  M. Valsecchi,et al.  Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  W. Kamps,et al.  Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high? , 2007, European journal of cancer.

[4]  M. Schrappe,et al.  Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial , 2007, The Lancet.

[5]  S. Richards,et al.  Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial , 2005, British journal of haematology.

[6]  N. Heerema,et al.  Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 2003, Blood.

[7]  H. Cavé,et al.  Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report , 2000, Leukemia.

[8]  C. Pui,et al.  Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children , 1996, The Lancet.

[9]  W. Kamps,et al.  High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. C. Bailey,et al.  Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X , 1995, The Lancet.

[11]  H. Sather,et al.  Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Lilleyman,et al.  Importance of 6-mercaptopurine dose in lymphoblastic leukaemia. , 1991, Archives of disease in childhood.

[13]  J. Holland,et al.  Chemotherapy of acute lymphocytic leukemia of childhood , 1972, Cancer.

[14]  Jiang Xue-qiang,et al.  Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia , 2010 .

[15]  A. Moghrabi,et al.  Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981–1995) , 2000, Leukemia.

[16]  C. Pui,et al.  Avascular femoral head necrosis in pediatric cancer patients. , 1993, Medical and pediatric oncology.

[17]  J. Shuster,et al.  Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia. , 1991, Medical and pediatric oncology.

[18]  R. Gelber,et al.  More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials. , 1990, Haematology and blood transfusion.

[19]  G. Henze,et al.  Results and significance of six randomized trials in four consecutive ALL-BFM studies. , 1990, Haematology and blood transfusion.

[20]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.